Eswatini vs Spain: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Eswatini
90.0%
in 2025
Spain
89.0%
in 2025
Eswatini rank
70th
Spain rank
72nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Eswatini
- Spain
How they compare
Eswatini currently reports 90.0% against 89.0% in Spain, a difference of 1.0%.
The two have swapped places 5 times across 18 shared years of data; in 2008 it was Spain ahead.
Eswatini ranks 70th and Spain ranks 72nd of 194 countries.
Across the 3 decades both report, Eswatini averaged higher in 1 and Spain in 1.
Head to head by decade
| Decade | Eswatini | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 50.9% | 27.8% | 23.1% | Eswatini |
| 2020s | 79.3% | 92.5% | 13.2% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Eswatini or Spain?
- Eswatini, at 90.0% against 89.0% in Spain as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Eswatini and Spain?
- 1.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Spain?
- 18 years are reported by both, from 2008 to 2025.
- How do Eswatini and Spain rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Eswatini ranks 70th and Spain ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.